- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Study the association of interleukins-8 and 39 with some biochemical variables in prostate cancer patients | ||
| Journal of University of Anbar for Pure Science | ||
| Volume 19, Issue 2, November and December 2025, Pages 65-72 PDF (478.38 K) | ||
| Document Type: Research Paper | ||
| DOI: 10.37652/juaps.2025.158122.1362 | ||
| Authors | ||
| Sahar Fraih Hasan* ; Nadea Ahmed Saleh | ||
| Department of Chemistry, College of Education for pure Science, University of Tikrit, Iraq | ||
| Abstract | ||
| Prostate cancer (PC) is a disease that primarily affects older men, and nearly one in eight men will develop it during their lifetime. The most common form occurs after the age of 50. We assessed whether interleukin-8 (IL-8) and interleukin-39 (IL-39) are associated with selected biochemical parameters in Iraqi patients with PC. This investigation included 42 patients with PC from the oncology center in Ramadi and 42 healthy controls (HCs). Serum levels of IL-8, IL-39, and prostate-specific antigen (PSA) were measured using the enzyme-linked immunosorbent assay (ELISA) method. Urea, creatinine, total bilirubin (TBIL), total calcium (TCa), and zinc (Zn) were determined using enzymatic colorimetric methods. PC patients had significantly higher serum IL-8 and IL-39 levels than HCs (p < 0.0001). IL-39 showed a significant correlation with IL-8, hemoglobin (Hb), PSA, and urea, while IL-8 and IL-39 showed no significant association with the other measured parameters. The analyzed parameters showed the following descending order for the area under the receiver operating characteristic (AUROC) curve; PSA (1.0), hemoglobin (Hb) (0.9802), urea (0.9572), TCa (0.7577), IL-39 (0.7321), TBIL (0.7271), IL-8 (0.6706), creatinine (0.6670), red blood cells (RBCs) (0.6440), and white blood cells (WBCs) (0.6301). Serum IL-8 and IL-39 levels were significantly correlated with each other. IL-8 showed a weak and non-significant correlation with the other measured parameters, whereas IL-39 showed a significant association only with PSA and Hb. | ||
| Keywords | ||
| Hemoglobin; PSA; Urea; WBCs; Zinc | ||
| References | ||
|
[1] Tătaru OS, Vartolomei MD, Rassweiler JJ, Virgil O, Lucarelli G, Porpiglia F, et al. Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives.Diagnostics. 2021;11(2):354.10.3390/diagnostics11020354 [2] Miyahira AK, Sharp A, Ellis L, Jones J, Kaochar S, Larman HB, et al. Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting.The Prostate. 2019;80(2):113–132.10.1002/pros.23934 [3] Mohler JL, Antonarakis ES, Armstrong AJ, D’Amico AV, Davis BJ, Dorff T, et al.Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology.Journal of the National Comprehensive Cancer Network. 2019;17(5):479-505.10.6004/jnccn.2019.0023 [4] Mao C, Ding Y, Xu N.A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy. Frontiers in Oncology. 2021;11.10.3389/fonc.2021.688489 [5] Adekoya TO, Richardson RM.Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis. International Journal of Molecular Sciences. 2020;21(12):4449.10.3390/ijms21124449 [6] Al-rawi KF, Ali HH, Guma MA, Mohammed Aldahham BJ, Tuleab Alaaraji SF, Al-ani O, et al. Relationship Between IL-2, IL-17 Concentrations, and Serum Creatinine Levels in Men with Chronic Kidney Diseases. Reports of Biochemistry and Molecular Biology. 2022;10(4):664–674. 10.52547/rbmb.10.4.664 [7] Ugge H, Downer MK, Carlsson J, Bowden M, Davidsson S, Mucci LA, et al.Circulating inflammation markers and prostate cancer.The Prostate. 2019;79(11):1338–1346.10.1002/pros.23842 [8] Alaaraji S, Mohisen M, Awad M.Assessment serum levels of neopterin, IL-6, IL-1𝛽, hs-CRP, TNF-𝛼 and MMP 9 in iraqi rheumatoid arthritis patients.Systematic Reviews in Pharmacy. 2020;11(12):88-93 [9] Maynard JP, Ertunc O, Kulac I, Baena-Del Valle JA, De Marzo AM, Sfanos KS. IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer.Molecular Cancer Research. 2020;18(1):153–165.10.1158/1541-7786.mcr19-0595 [10] Henkels KM, Frondorf K, Gonzalez-Mejia ME, Doseff AL, Gomez-Cambronero J.IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3).FEBS Letters. 2010;585(1):159–166. 10.1016/j.febslet.2010.11.031 [11] Matsushima K, Yang D, Oppenheim JJ. Interleukin-8: An evolving chemokine. Cytokine. 2022;153:155828.10.1016/j.cyto.2022.155828 [12] Cheng Y, Ma Xl, Wei Yq, Wei XW.Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases.Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2019;1871(2):289–312.10.1016/j.bbcan.2019.01.005 [13] Roumeguère T, Legrand F, Rassy EE, Kaitouni MI, Albisinni S, Rousseau A, et al.A Prospective Clinical Study of the Implications of IL-8 in the Diagnosis, Aggressiveness and Prognosis of Prostate Cancer.Future Science OA. 2017;4(2).10.4155/fsoa-2017-0084 [14] Sharma J, Gray KP, Harshman LC, Evan C, Nakabayashi M, Fichorova R, et al. Elevated IL-8, TNF-𝛼, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival.The Prostate. 2014;74(8):820–828.10.1002/pros.22788 [15] Maynard JP, Ertunc O, Kulac I, Baena-Del Valle JA, De Marzo AM, Sfanos KS. IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer.Molecular Cancer Research. 2020;18(1):153–165.10.1158/1541-7786.mcr19-0595 [16] Lu Z, Xu K, Wang X, Li Y, Li M.Interleukin 39: a new member of interleukin 12 family.Central European Journal of Immunology. 2020;45(2):214–217.10.5114/ceji.2020.97911 [17] Tachibana K, Tang N, Urakami H, Kajita A, Kobashi M, Nomura H, et al.Multifaceted Analysis of IL-23A- and/or EBI3-Including Cytokines Produced by Psoriatic Keratinocytes.International Journal of Molecular Sciences. 2021;22(23):12659.10.3390/ijms222312659 [18] Luo Y, Liu F, Liu H, Chen H, Cheng W, Dong S, et al. Elevated Serum IL-39 in Patients With ST-segment Elevation Myocardial Infarction was Related with Left Ventricular Systolic Dysfunction. Biomarkers in Medicine. 2017;11(6):419–426.10.2217/bmm-2016-0361 [19] Alaaraji SFT.Exploration of the Relationship between Interleukins 17, 37 and 38 with Vitamin E in Iraqi Men with CHB.In: Journal of Physics: Conference Series. vol. 1294. IOP Publishing; 2019. p. 052047 [20] Al-Kaif LAIK, Al-Khafaji YAK, Shandaway SK, AL-Janabi UHK, Kadhim KJ, Akkaif MA. Interleukin-8 and -17 Levels in the Sera of Vaccinated Subjects Receiving a Booster Dose of Measles Virus: A Follow-up Study in Iraq. Medical Journal of Babylon. 2023;20(2):422–425. 10.4103/mjbl.mjbl_566_23 [21] Gandaglia G, Leni R, Bray F, Fleshner N, Freedland S, Kibel A, et al.. Epidemiology and Prevention of Prostate Cancer. European Urology Oncology; 2021;4(6).10.1016/j.euo.2021.09.006 [22] Hjelmborg JB, Scheike T, Holst K, Skytthe A, Penney KL, Graff RE, et al. The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer.Cancer Epidemiology, Biomarkers & Prevention. 2014;23(11):2303–2310.10.1158/1055-9965.epi-13-0568 [23] Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA.Chronic Inflammation and Cytokines in the Tumor Microenvironment. Journal of Immunology Research. 2014;2014:1–19. 10.1155/2014/149185 [24] Waugh DJJ, Wilson C. The Interleukin-8 Pathway in Cancer. Clinical Cancer Research. 2008;14(21):6735–6741.10.1158/1078-0432.ccr-07-4843 [25] Araki S, Omori Y, Lyn D, Singh RK, Meinbach DM, Sandman Y, et al.Interleukin-8 Is a Molecular Determinant of Androgen Independence and Progression in Prostate Cancer. Cancer Research. 2007;67(14):6854–6862.10.1158/0008-5472.can-07-1162 [26] Chi N, Tan Z, Ma K, Bao L, Yun Z.Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and-6 in prostate cancer. International journal of clinical and experimental medicine. 2014;7(10):3181 [27] Khaliefa AK, Desouky EM, Hozayen WG, Shaaban SM, Hasona NA.miRNA-1246, HOTAIR, and IL-39 signature as potential diagnostic biomarkers in breast cancer. Non-coding RNA Research. 2023;8(2):205–210.10.1016/j.ncrna.2023.02.002 [28] Manning AA, Zhao L, Zhu Z, Xiao H, Redington CG, Ding VA, et al.Correction to: IL-39 acts as a friend to pancreatic cancer.Medical Oncology. 2019;36(2).10.1007/s12032-018-1244-y [29] XIAO H, ALISIC H, REIMAN BT, DENG Z, ZHU Z, GIVENS NT, et al.IL-39 Reduces Proliferation and Promotes Apoptosis of Bladder Cancer by Altering the Activity of Cyclin E and Fas.Anticancer Research. 2021;41(5):2239–2245.10.21873/anticanres.15000 [30] Weng L, Huang G, Gong L, Xu J, Mao Y, Li Y, et al.Low levels of serum IL-39 are associated with autoimmune thyroid disease.Journal of Clinical Laboratory Analysis. 2022;36(4).10.1002/jcla.24284 [31] Tarantino G, Crocetto F, Vito CD, Martino R, Pandolfo SD, Creta M, et al.Clinical Factors Affecting prostate-specific Antigen Levels in Prostate Cancer Patients Undergoing Radical Prostatectomy: a Retrospective Study.Future Science OA. 2021;7(3).10.2144/fsoa-2020-0154 [32] Farris MS, Courneya KS, Kopciuk KA, McGregor SE, Friedenreich CM.Anthropometric measurements and survival after a prostate cancer diagnosis.British Journal of Cancer. 2017;118(4):607–610. 10.1038/bjc.2017.440 [33] Raju T, Kaur J, Gupta M, Kumar V.Virchow’s Node Metastasis Due to Prostate Malignancy: A Rare Case.Medical Journal of Babylon. 2022;19(3):499–502.10.4103/mjbl.mjbl_65_22 [34] Inoguchi T, Nohara Y, Nojiri C, Nakashima N. Association of serum bilirubin levels with risk of cancer development and total death.Scientific Reports. 2021;11(1).10.1038/s41598-021-92442-2 [35] Kühn T, Sookthai D, Graf ME, Schübel R, Freisling H, Johnson T, et al.Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study.British Journal of Cancer. 2017;117(10):1572–1579.10.1038/bjc.2017.313 [36] Liao J, Schneider A, Datta NS, McCauley LK. Extracellular Calcium as a Candidate Mediator of Prostate Cancer Skeletal Metastasis.Cancer Research. 2006;66(18):9065–9073.10.1158/00085472.can-06-0317 [37] Watts EL, Perez-Cornago A, Kothari J, Allen NE, Travis RC, Key TJ. Hematologic Markers and Prostate Cancer Risk: A Prospective Analysis in UK Biobank.Cancer Epidemiology, Biomarkers & Prevention. 2020;29(8):1615–1626.10.1158/1055-9965.epi-19-1525 [38] Dai D, Han S, Li L, Guo Y, Wei Y, Jin H, et al.Anemia is associated with poor outcomes of metastatic castration-resistant prostate cancer, a systematic review and meta-analysis. American journal of translational research. 2018;10(12):3877 | ||
|
Statistics Article View: 336 PDF Download: 162 |
||